期刊文献+
共找到442篇文章
< 1 2 23 >
每页显示 20 50 100
补充褪黑素的人卵母细胞体外培养成熟技术在COH周期中的应用
1
作者 任宇 韩星星 +4 位作者 张琦琦 刘璐 许孝凤 章志国 邹慧娟 《安徽医科大学学报》 CAS 北大核心 2024年第6期983-988,共6页
目的比较同一控制性超促排卵(COH)治疗周期中,体内成熟与改良技术体外培养成熟(IVM)的卵母细胞的早期胚胎发育能力及临床结局,探讨补充褪黑素的IVM技术在临床中的应用。方法收集159例患者在COH周期中的920个成熟卵母细胞进行常规体外受... 目的比较同一控制性超促排卵(COH)治疗周期中,体内成熟与改良技术体外培养成熟(IVM)的卵母细胞的早期胚胎发育能力及临床结局,探讨补充褪黑素的IVM技术在临床中的应用。方法收集159例患者在COH周期中的920个成熟卵母细胞进行常规体外受精(IVF/ICSI)处理,同时收集同周期中1283个未成熟卵母细胞,在添加褪黑素的改良IVM培养基中培养成熟后行ICSI处理。通过回顾性分析,比较常规助孕技术与改良IVM技术这两种方式,对辅助生殖治疗的助孕结局和妊娠结局的影响。结果与从COH周期中收集到的行常规IVF/ICSI处理的成熟卵母细胞相比,经改良IVM技术促成熟的卵母细胞的优质囊胚形成率较低。但经胚胎移植后,两种方式获得的成熟卵母细胞的临床结局包括临床妊娠率、足月产率、婴儿体长、新生儿Apgar评分,差异均无统计学意义。结论IVM可以提高从COH周期中回收的未成熟卵母细胞的卵子利用率,改善辅助生殖技术助孕患者的妊娠结局。 展开更多
关键词 卵母细胞 体外培养成熟技术 体外受精 控制性超促排卵 妊娠结局
下载PDF
Effect and Underlying Mechanism of Bu-Shen-An-Tai Recipe on Ovarian Apoptosis in Mice with Controlled Ovarian Hyperstimulation Implantation Dysfunction 被引量:2
2
作者 马雯雯 肖静 +4 位作者 宋玙璠 丁嘉慧 谈秀娟 宋坤琨 张明敏 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2017年第3期401-406,共6页
The effect and underlying mechanism of Bu-Shen-An-Tai recipe on ovarian apoptosis in mice with controlled ovarian hyperstimulation(COH) implantation dysfunction were studied. The COH implantation dysfunction model in ... The effect and underlying mechanism of Bu-Shen-An-Tai recipe on ovarian apoptosis in mice with controlled ovarian hyperstimulation(COH) implantation dysfunction were studied. The COH implantation dysfunction model in mice was established by intraperitoneal injection of 7.5 IU pregnant mare’s serum gonadotrophin(PMSG), followed by 7.5 IU human chorionic gonadotrophin(HCG) 48 h later. Then the female mice were mated with male at a ratio of 2:1 in the same cage at 6:00 p.m. The female mice from normal group were injected intraperitoneally with normal saline and mated at the corresponding time. Day 1 of pregnancy was recorded by examining its vaginal smears at 8:00 a.m. of the next day. Fifty successfully pregnant mice were equally randomly divided into 5 groups: normal control pregnant group(NC), COH implantation dysfunction model group(COH), low dosage of Bu-Shen-An-Tai recipe group(LOW), middle dosage of Bu-Shen-An-Tai recipe group(MID) and high dosage of Bu-Shen-An-Tai recipe group(HIGH). Then from day 1, the mice in different groups were respectively intragastrically given corresponding treatments at 9:00 a.m. for 5 consecutive days. The concentrations of 17β-estradiol(E) and progesterone(P) were determined by radioimmunoassay(RIA). The ultrastructural changes of ovarian tissues were observed by transmission electron microscope(TEM). The histopathological changes of ovarian tissues were observed by HE staining. The number of atretic follicles and pregnant corpus luteum were also recorded. TUNEL was applied to measure apoptotic cells of ovarian tissues. Western blotting was used to detect the protein expression of apoptosis-related factors like Bax, Bcl-2 and cleaved-caspase-3 in ovarian tissue of mice. The results showed that ovarian weight, the concentrations of Eand P, the number of atretic follicles and pregnant corpus luteum, as well as the apoptosis of granulosa cells were significantly increased in the COH group. The ultrastructures of ovarian tissues in the COH group showed that chromatin in granulosa cells was increased, agglutinated, aggregated or crescent-shaped. The focal cavitation and the typical apoptotic bodies could be seen in granulosa cells in the late stage of apoptosis. After the treatment with different doses of Bu-Shen-An-Tai recipe, the ultrastructural changes of ovarian granulosa cells apoptosis were dramatically improved and even disappeared under TEM. Visible mitochondria and mitochondrial cristae were increased and vacuoles were significantly reduced. The lipid dropltes were shown in a circluar or oval shape. The protein expression levels of Bax and cleaved-caspase-3 were decreased, and the expression of Bcl-2 protein was increased after treatment. It was concluded that Bu-Shen-An-Tai recipe can inhibit the apoptosis of ovarian granulosa cells, probably by up-regulating the protein expression of Bcl-2 and down-regulating Bax and cleaved-caspase-3, which contributes to the formation and maintenance of ovarian corpus luteum. It’s helpful to promote the embryonic implantation, to reduce embryo loss and ultimately to improve the success rate of pregnancy. 展开更多
关键词 controlled ovarian hyperstimulation Bu-Shen-An-Tai recipe implantation dysfunction ovary APOPTOSIS
下载PDF
Endometrial Mucin-1 and Pinopode in Peri-implantation Phase in Ovarian High Responders during Controlled Ovarian Hyperstimulation Cycles
3
作者 Qiu-ju CHEN Xiao-xi SUN Lu LI Xiao-hong GAO Yu WU Li-nan CHENG 《Journal of Reproduction and Contraception》 CAS 2007年第3期187-196,共10页
Objective To investigate effects of ovarian high response on endometrial mucin-1 (MUC1) and pinopode in peri-implantation phase in controlled ovarian hyperstimulation (COH) cycles. Methods Ovarian high response wa... Objective To investigate effects of ovarian high response on endometrial mucin-1 (MUC1) and pinopode in peri-implantation phase in controlled ovarian hyperstimulation (COH) cycles. Methods Ovarian high response was defined as serum E2 〉 15 000 pmol/L on the day of hCG administration in COH cycle using GnRH agonist and recombinant FSH (n=8). Healthy and fertile women were used as the natural control (n=10). Endometrial biopsies were performed on the day of LH+ 7/hCG+ 7. Pinopode formation was observed by scanning electron microscope. Expression of MUC1 was detected with quantitative Real-time PCR and immunohistochemistry. Results In high response group, the lumen surface was covered with variant pinopodes and microvillous. The expression of MUC1 mRNA in high response group was lower than that in the natural control (P〈0.05). Immunostaining for MUC1 protein in glandular and luminal epithelium in high response group was lower than that in the natural control (P〈0. 05). Conclusion Asynchronized pinopode appearance and lower expression of MUC1 during peri-implantation period were the characteristics of endometrium in high response group, Which may provide a clue of decreased endometrial receptivity in the supraphysiological hormone milieu. 展开更多
关键词 ENDOMETRIUM controlled ovarian hyperstimulation high response mucin-1 pinopode
下载PDF
Missed estradiol determination resulting in oocyte retrieval and embryo development following controlled ovarian hyperstimulation at early pregnancy: Case report
4
作者 Maryam Eftekhar Azam Agha-Rahimi +1 位作者 Mohammad Ali Khalili Marjan Omidi 《Asian pacific Journal of Reproduction》 2018年第3期143-144,共2页
This paper is a case report on the success of oocyte retrieval and good quality embryo development following controlled ovarian hyperstimulation at early pregnancy. A 30-year-old patient underwent controlled ovarian h... This paper is a case report on the success of oocyte retrieval and good quality embryo development following controlled ovarian hyperstimulation at early pregnancy. A 30-year-old patient underwent controlled ovarian hyperstimulation by gonadotropin-releasing hormone agonist long protocol. On the day of oocyte collection, a 5-week gestational sac was observed by exact sonography monitoring. However, via ultrasound guided follicle puncture, 7 oocytes were collected. After intarcytoplasmic sperm injection, 3 developed good quality embryos were cryopreserved. Moreover, the natural pregnancy was continued and finally a healthy live birth was achieved. Despite physiological hormonal changes during pregnancy, the follicular growth occurred and followed by oocyte retrieval and embryo development, subsequently. 展开更多
关键词 controlled ovarian hyperstimulation OOCYTE EMBRYO Pregnancy
下载PDF
Pharmacotherapy Cost of Controlled Ovarian Hyperstimulation of <i>in Vitro</i>Fertilization—A Real Life Study
5
作者 Boriana V. Benbassat Miglena Doneva Guenka I. Petrova 《Pharmacology & Pharmacy》 2014年第10期919-925,共7页
The aim of the current study is to analyze the cost of controlled ovarian hyperstimulation (COH) of in vitro fertilization (IVF) during the period 2009-2013 in a specialized gynecology clinic. It is a prospective, obs... The aim of the current study is to analyze the cost of controlled ovarian hyperstimulation (COH) of in vitro fertilization (IVF) during the period 2009-2013 in a specialized gynecology clinic. It is a prospective, observational study and bottom up cost analysis of the COH pharmacotherapy of IVF. The data was collected for all women admitted to the clinic, therapeutic COH protocols, prescribed medicines and doses, average length of therapy and its cost. Statistical analysis is applied towards the pharmacotherapy and cost data. On average 136 (SD 21.92) women were admitted varying from 105 to 179 for 10.7 (SD 1.47) days. 11% were on long (GnRH agonist containing) therapeutic COH protocol and all other on short (GnRH antagonist containing). Therapeutic protocols include Follitropin-α IU (103 women at average dose of 1171 IU (SD 314.16));Follitropin-β IU (299 women at average dose of 1634 IU (SD 423.5));Urofollitropin 75 IU amp (243 women at average dose of 21.3 IU (SD 7.37));urFSH + urLH 75IU:75IU/amp (354 women at average dose of 23.4 IU (SD 8.8));cetrorelix amp 0.25 mg prescribed at 264 women at average dose of 3.84 IU (SD 1.32);ganirelix amp 0.25 mg for 299 women at average dose of 4.01 mg (SD 1.32);Human chorion gonadotropin for 535 women at average dose of 6752.52 IU (SD 1216.23);Nafarelin mcg/ml for 8 women at dose of 17,700 mcg (SD 10,725);triptorelinacetat 0.1 mg amp - 63 women at doses of 5.5 (SD 3.25) mg at 14 women and average dose of 7.5 mg (SD 2.5);clomiphen citrate and letrozole for 15 women at average dose of 8 mg (SD 2.4). The average cost of COH pharmacotherapy is varying among the years with highest value of 1803.776 (SD - 624.89) BGN in 2009. Controlled ovarian hyperstimulation of in vitro fertilization is cost and resource consuming procedure in regards to pharmacotherapy. Age and reason of infertility influence significantly the cost. 展开更多
关键词 controlled ovarian hyperstimulation In Vitro FERTILIZATION PHARMACOTHERAPY COST Analysis
下载PDF
Treatment of Unexplained Infertility by Acupuncture in Natural and Control Ovarian Hyperstimulation Cycles: A Prospective Analysis
6
作者 Liuhong Cai Rihan Hai +3 位作者 Bin Zhang Yanfei Wen Minhui Zeng Manbo Jiang 《Advances in Reproductive Sciences》 2014年第4期88-92,共5页
Acupuncture is an important method of treatment in Chinese medicine. The objective of this study was to evaluate the efficacy of acupuncture as an adjuvant treatment for unexplained infertility. Here we conducted a pr... Acupuncture is an important method of treatment in Chinese medicine. The objective of this study was to evaluate the efficacy of acupuncture as an adjuvant treatment for unexplained infertility. Here we conducted a prospective study, with data consisting of acupuncture group (38 cases) and control group (42 cases). Infertility evaluation workup consisted of semen analysis, ovulation assessment, hysterosalpingogram (HSG) and blood analysis. The patients in acupuncture group received 3 acupuncture sessions, and each at seven acupuncture points (EX-CA1, CV4, CV6, SP10, ST36, SP6, and KI3). The session started 12 days before menstruation and continued for 10 days. The patients in control group did not receive acupuncture. All patients tried 1 - 3 natural cycles 3 months after HSG test, if not pregnant, underwent 1 - 3 cycles of control ovarian hyperstimulation (COH) and timed intercourse. Pregnancy was evaluated by measurement of blood β human chorionic gonadotrophin (β-hCG) and subsequent trans-vaginal ultrasound. No significant difference of clinical pregnancy rate was found between the acupuncture group and the control group, however, numbers of COH cycles were significantly less and more pregnancies occurred in natural cycle in the acupuncture group. We concluded that acupuncture can be used as an adjuvant treatment for unexplained infertility. Although acupuncture did not increase the cumulative pregnancy rate, it decreased the number of COH cycles and more patients got pregnant in natural cycles after receiving acupuncture. 展开更多
关键词 ACUPUNCTURE UNEXPLAINED INFERTILITY Control ovarian hyperstimulation Pregnancy
下载PDF
COH过程中雌二醇下降对拮抗剂方案IVF-ET助孕结局的影响 被引量:1
7
作者 徐玲 刘尧芳 《生殖医学杂志》 CAS 2023年第11期1637-1642,共6页
目的分析拮抗剂方案控制性促排卵(COH)过程中雌二醇(E_(2))水平下降对体外受精/卵胞浆内单精子注射-胚胎移植(IVF/ICSI-ET)助孕结局的影响。方法回顾性分析2019年1月至2022年12月于我院生殖医学科行IVF/ICSI-ET时采用拮抗剂方案促排卵的... 目的分析拮抗剂方案控制性促排卵(COH)过程中雌二醇(E_(2))水平下降对体外受精/卵胞浆内单精子注射-胚胎移植(IVF/ICSI-ET)助孕结局的影响。方法回顾性分析2019年1月至2022年12月于我院生殖医学科行IVF/ICSI-ET时采用拮抗剂方案促排卵的385个周期的临床资料,根据患者促排卵过程中E_(2)水平的变化情况分为3组:扳机日前E_(2)下降者为A组(n=38)、扳机日E_(2)下降者为B组(n=81),促性腺激素(Gn)使用过程中E_(2)持续上升者为C组(n=266),比较各组患者的一般情况及IVF-ET结局。结果各组患者间年龄、抗苗勒管激素(AMH)、基础窦卵泡计数(AFC)及基础性激素水平等一般资料比较均无显著性差异(P>0.05)。A组和B组扳机日E_(2)水平、孕酮水平、LH水平、E_(2)/≥14 mm卵泡数、获卵数及扳机日E_(2)/获卵数均显著低于C组(P<0.05);A组的Gn使用天数显著多于B组和C组,而Gn启动剂量显著低于B组和C组(P<0.05);A组和B组的MⅡ卵数、2PN受精数、优质胚胎数均略低于C组,但尚无显著性差异(P>0.05);各组患者新鲜胚胎移植后的胚胎种植率、临床妊娠率比较亦无显著性差异(P>0.05)。结论采用拮抗剂方案促排卵过程中,E_(2)的下降可能会影响扳机日的E_(2)、孕酮、LH水平及获卵数,但对胚胎质量和新鲜胚胎移植结局可能无显著影响。 展开更多
关键词 体外受精-胚胎移植 控制性促排卵 拮抗剂方案 雌二醇
下载PDF
黄体期长方案与拮抗剂方案在首次拮抗剂失败后PCOS患者中的应用比较
8
作者 王田娟 王超 +6 位作者 邢琼 徐玉萍 张文香 周平 许孝凤 魏兆莲 曹云霞 《安徽医科大学学报》 CAS 北大核心 2024年第6期976-982,共7页
目的探讨首次拮抗剂治疗失败的多囊卵巢综合征(PCOS)患者再次超促排卵时分别采用黄体期长方案和拮抗剂方案诱导排卵的临床效果及妊娠结局的优劣。方法检索首次采用拮抗剂方案行IVF/ICSI-ET助孕失败后再次超促排卵的PCOS患者163例,根据... 目的探讨首次拮抗剂治疗失败的多囊卵巢综合征(PCOS)患者再次超促排卵时分别采用黄体期长方案和拮抗剂方案诱导排卵的临床效果及妊娠结局的优劣。方法检索首次采用拮抗剂方案行IVF/ICSI-ET助孕失败后再次超促排卵的PCOS患者163例,根据第二次超促排卵方案,分为黄体期长方案组(共95例)和拮抗剂方案组(共68例)。回顾性分析比较两组患者的基础临床资料、临床及实验室指标及妊娠结局。结果①两组患者的基础临床指标除了LH,其他指标差异均无统计学意义。②黄体期长方案组患者自身超排卵对比,促性腺激素(Gn)启动剂量、Gn总天数、Gn总使用量、hCG注射日雌二醇(E_(2))值、获卵数、卵子成熟率、2PN受精数、2PN卵裂数、囊胚形成率、优质囊胚形成率显著高于首次拮抗剂周期(P<0.05)。拮抗剂方案组患者自身超排卵对比也观察到类似改善。③两组第二次超促排卵周期比较,黄体期长方案组Gn总天数、总用量、总费用较高(P<0.05),而hCG注射日E_(2)及LH水平、卵子成熟率显著低于拮抗剂方案(P<0.05),但两组间获卵数、2PN受精数、2PN卵裂数、囊胚形成率、OHSS率差异无统计学意义。④两组第二次超促排卵新鲜移植周期比较,黄体期长方案新鲜移植率、种植率、临床妊娠率及活产率略高,但差异无统计学意义。首次解冻周期的妊娠结局比较,拮抗剂组的生化妊娠率、临床妊娠率高于黄体期长方案组(P<0.05),但着床率、活产率、新生儿胎龄及出生体质量差异无统计学意义。结论对于首次拮抗剂方案治疗失败的患者,适当增加Gn启动剂量及用量,两种方案均能获得满意的妊娠结局。相较于黄体期长方案,再次使用拮抗剂方案保持了其优势,包括治疗周期短、成本低、患者依从性好。 展开更多
关键词 多囊卵巢综合征 体外受精 黄体期长方案 拮抗剂方案 控制性促排卵
下载PDF
控制性超促排卵对子宫内膜的影响 被引量:1
9
作者 马玉聪 焦元清 +3 位作者 张拴成 高星 杨海军 宋翠淼 《生理科学进展》 CAS 北大核心 2024年第1期86-90,共5页
控制性超促排卵(controlled ovarian hyperstimulation,COH)是辅助生殖技术的重要组成部分,可显著提高体外受精-胚胎移植(in vitro fertilization-embryo transfer,IVF-ET)的妊娠率。尽管COH在促进卵泡发育和获取卵母细胞数量方面可获... 控制性超促排卵(controlled ovarian hyperstimulation,COH)是辅助生殖技术的重要组成部分,可显著提高体外受精-胚胎移植(in vitro fertilization-embryo transfer,IVF-ET)的妊娠率。尽管COH在促进卵泡发育和获取卵母细胞数量方面可获得明显的益处,并能够选择高质量的胚胎进行移植,但COH可能涉及种植窗、子宫内膜容受性、孕酮和雌二醇以及子宫收缩功能的改变,影响不孕患者的胚胎种植率和IVF妊娠率。本文就COH后子宫内膜变化的病理生理机制进行综述,以更好地解决不孕症临床治疗的瓶颈问题。 展开更多
关键词 控制性超促排卵 子宫内膜 体外受精 胚胎移植
下载PDF
经后增殖方对控制性超促排卵大鼠卵巢GDF9分泌及颗粒细胞凋亡的影响 被引量:1
10
作者 杨贞 江少如 +3 位作者 陈小燕 陈晓琳 邓伟民 郭新宇 《实用医学杂志》 CAS 北大核心 2024年第7期918-923,共6页
目的观察益气血法经后增殖方通过p38MAPK/CK2/IκBα/NF-κB通路对控制性超促排卵(COH)大鼠卵巢GDF9分泌及颗粒细胞(GCs)凋亡的影响。方法建立COH大鼠模型,18只大鼠随机分为自然排卵组(NO组)、COH组、COH+经后增殖方组(COH+JHZZG组)。qR... 目的观察益气血法经后增殖方通过p38MAPK/CK2/IκBα/NF-κB通路对控制性超促排卵(COH)大鼠卵巢GDF9分泌及颗粒细胞(GCs)凋亡的影响。方法建立COH大鼠模型,18只大鼠随机分为自然排卵组(NO组)、COH组、COH+经后增殖方组(COH+JHZZG组)。qRT-PCR和Western blot法检测p38MAPK、CK2、IκBα、NF-κB、GDF9 mRNA和蛋白的表达水平,TUNEL法检测卵巢GCs凋亡率。结果与NO组比较,COH组大鼠卵巢组织p38MAPK、NF-κB表达升高,CK2、IκBα、GDF9表达下降,卵巢GCs凋亡率升高,差异有统计学意义(P<0.01);与COH组比较,COH+JHZZG组大鼠卵巢组织p38MAPK、NF-κB表达下降,CK2、IκBα、GDF9表达升高,差异有统计学意义(P<0.01);卵巢GCs凋亡率下降,差异有统计学意义(P<0.05)。结论益气血法经后增殖方通过p38MAPK/CK2/IκBα/NF-κB通路促进COH大鼠卵巢GDF9的分泌,抑制卵巢GCs的凋亡,从而提高COH卵细胞质量。 展开更多
关键词 经后增殖方 控制性超促排卵 P38MAPK NF-κB GDF9 细胞凋亡
下载PDF
经后增殖方含药血清对超排卵大鼠卵巢颗粒细胞GDF9表达及凋亡的调控机制 被引量:1
11
作者 杨贞 陈小燕 +4 位作者 江少如 叶淑珠 方晓宏 邓伟民 郭新宇 《广州中医药大学学报》 CAS 2024年第3期735-741,共7页
【目的】观察益气血法经后增殖方含药血清对超排卵大鼠卵巢颗粒细胞生长分化因子9(GDF9)表达及凋亡的调控机制。【方法】制备超排卵大鼠血清(空白血清)和经后增殖方灌胃的超排卵大鼠血清(含药血清)。建立控制性超排卵(COH)大鼠模型,收... 【目的】观察益气血法经后增殖方含药血清对超排卵大鼠卵巢颗粒细胞生长分化因子9(GDF9)表达及凋亡的调控机制。【方法】制备超排卵大鼠血清(空白血清)和经后增殖方灌胃的超排卵大鼠血清(含药血清)。建立控制性超排卵(COH)大鼠模型,收集卵巢颗粒细胞。实验分为5组:空白血清组,含药血清组,含药血清+SB203580[p38丝裂原活化蛋白激酶(p38MAPK)抑制剂]组,含药血清+PDTC[核转录因子κB(NF-κB)抑制剂]组,含药血清+SB203580+PDTC组。采用实时定量聚合酶链反应(qRT-PCR)法检测p38MAPK、酪蛋白激酶2(CK2)、核转录因子κB抑制因子α(IκBα)、NF-κB、GDF9 mRNA表达水平,蛋白免疫印迹(Western Blot)法检测GDF9蛋白表达水平,脱氧核糖核苷酸末端转移酶介导的缺口末端标记法(TUNEL)检测卵巢颗粒细胞凋亡。【结果】经后增殖方含药血清降低COH大鼠卵巢颗粒细胞的p38MAPK和NF-κB mRNA表达,升高CK2和IκBαmRNA表达,提高GDF9 mRNA和蛋白的表达水平,降低卵巢颗粒细胞的凋亡率。单独添加p38MAPK抑制剂SB203580与单独添加NF-κB抑制剂PDTC均能促进GDF9 mRNA和蛋白表达、降低卵巢颗粒细胞凋亡率。【结论】益气血法经后增殖方含药血清可促进超排卵大鼠卵巢颗粒细胞GDF9表达,抑制卵巢颗粒细胞凋亡,其机制可能与调控p38MAPK和NF-κB双信号通路基因表达有关。 展开更多
关键词 益气血法 经后增殖方 控制性超排卵(coh) 凋亡 生长分化因子9(GDF9) p38丝裂原活化蛋白激酶(p38MAPK) 核转录因子κB(NF-κB) 颗粒细胞
下载PDF
两种重组人卵泡刺激素注射液在不同人群中的促排卵效果分析
12
作者 季晓微 贺立颖 +4 位作者 陈玮 王琳 刘淼 刘素英 董曦 《生殖医学杂志》 CAS 2024年第4期427-434,共8页
目的探究具有不同糖修饰谱的两种重组人卵泡刺激素(rFSH)在不同人群中行控制性促排卵(COH)临床应用的有效性和安全性。方法回顾性分析2022年1—12月期间本中心的320个COH周期的临床资料,按照COH中使用的rFSH种类不同分为A组(芳乐舒,95... 目的探究具有不同糖修饰谱的两种重组人卵泡刺激素(rFSH)在不同人群中行控制性促排卵(COH)临床应用的有效性和安全性。方法回顾性分析2022年1—12月期间本中心的320个COH周期的临床资料,按照COH中使用的rFSH种类不同分为A组(芳乐舒,95个周期)和B组(Puregon,225个周期)。比较两组患者在起始剂量、刺激时间、HCG日激素水平和内膜厚度、获卵数、减数分裂Ⅱ期(MⅡ)卵率、受精率、卵裂率、有效胚胎率、卵母细胞利用率和胚胎利用率等方面的差异。结果在A、B两组患者的年龄[(34.9±4.9)岁vs.(33.3±4.5)岁,P=0.006]、体质量指数(BMI)[(22.5±3.2)kg/m^(2) vs.(21.6±2.6)kg/m^(2),P=0.027]存在一定差异的前提下,A组获卵数与B组相当[(11.2±7.0)vs.(12.9±7.3),P=0.059]。在拮抗剂方案COH周期,两组患者年龄相近(P>0.05),此时两组的获卵数[(13.7±7.1)vs.(14.8±7.6),P=0.340]及其他结局指标均无统计学差异(P>0.05)。将所有患者根据年龄分层分析,高龄(≥35岁)亚组中,A组患者受精率[(78.1±19.6)%vs.(69.1±25.8)%,P=0.039]、卵裂率[(98.9±3.2)%vs.(93.7±22.1)%,P=0.039]和卵母细胞利用率[(44.9±30.6)%vs.(34.1±23.5)%,P=0.037]显著高于B组;低龄(<35岁)亚组中,A、B两组患者各项结局指标均无统计学差异(P>0.05)。通过逐步多元回归分析,确定COH方案和年龄是获卵数的预测因素(P<0.001),最终回归模型可解释28.8%的反应变异性。结论芳乐舒与Puregon两种rFSH具有相似的获卵数和获胚结局,在高龄人群中芳乐舒诱导的卵母细胞质量可能较高。 展开更多
关键词 重组人卵泡刺激素 控制性促排卵 高龄 糖基化
下载PDF
121个染色体平衡易位携带者PGD周期COH的卵巢反应性分析 被引量:2
13
作者 郑叶 张楚 +2 位作者 颜军昊 唐蓉 陈子江 《现代妇产科进展》 CSCD 2014年第3期165-170,共6页
目的:探讨常染色体平衡易位对女性携带者控制性超促排卵(COH)中卵巢反应性的影响。方法:回顾分析于我院行胚胎植入前遗传学诊断(PGD)的109对常染色体平衡易位夫妇,共121个周期,其中夫妇中仅女方为平衡易位携带者56例(63个周期,研究组),... 目的:探讨常染色体平衡易位对女性携带者控制性超促排卵(COH)中卵巢反应性的影响。方法:回顾分析于我院行胚胎植入前遗传学诊断(PGD)的109对常染色体平衡易位夫妇,共121个周期,其中夫妇中仅女方为平衡易位携带者56例(63个周期,研究组),包括罗伯逊易位携带者23例(27个周期),相互易位携带者33例(36个周期);夫妇中仅男方为平衡易位携带者53例(58个周期,对照组),包括罗伯逊易位携带者30例(32个周期),相互易位携带者23例(26个周期)。分析COH过程中,研究组和对照组的女方卵巢反应性指标和妊娠结局。结果:两组的女方年龄、体重指数(BMI)、基础内分泌及窦卵泡数(AFC)均无显著差异(P>0.05)。两组的卵巢反应性指标,包括Gn总量、HCG注射日E2水平、获卵数、D3胚胎数、可移植胚胎数及移植胚胎数,以及移植周期临床妊娠率、早期流产率及种植率均无显著差异(P>0.05)。单独就罗伯逊易位携带者或相互易位携带者而言,两组的各指标均无显著差异。排除可能影响COH卵巢反应性的女方因素,研究组与对照组的各指标均无显著差异。结论:染色体平衡易位,包括罗伯逊易位或相互易位并不影响COH中的卵巢反应性。应将染色体平衡易位女性携带者视为正常卵巢反应性,采用合适剂量的促性腺激素进行控制性促排卵。 展开更多
关键词 染色体平衡易位 控制性超促排卵(coh) 卵巢反应性 胚胎植入前遗传学诊断(PGD) 罗伯逊易位 相互易位
下载PDF
长效GnRH-a长方案在年轻患者COH中应用优势的探讨 被引量:2
14
作者 吴重聪 杨桂艳 +1 位作者 阮永铭 李利映 《中国医学创新》 CAS 2014年第29期7-10,共4页
目的:通过比较促性腺激素释放激素(GnRH-a)长效长方案和短效长方案在控制性超排卵(COH)中应用的效果,探讨长效GnRH-a长方案在年轻患者体外受精-胚胎移植(IVF-ET)中应用的优势。方法:回顾性分析GnRH-a长效长方案(1045个周期)和GnRH-a短... 目的:通过比较促性腺激素释放激素(GnRH-a)长效长方案和短效长方案在控制性超排卵(COH)中应用的效果,探讨长效GnRH-a长方案在年轻患者体外受精-胚胎移植(IVF-ET)中应用的优势。方法:回顾性分析GnRH-a长效长方案(1045个周期)和GnRH-a短效长方案(555个周期)在年轻患者COH中应用的资料,按长方案降调节中使用长效或短效GnRH-a分为两组,观察比较两组超排卵效果及助孕结局。结果:在年轻患者中长效长方案组的促性腺激素(Gn)用量明显减少、超排时间延长、周期取消率升高,hCG日LH水平明显低于短效长方案组,获卵数、可移植胚胎数均明显多于短效长方案组,冷冻率明显高于短效长方案组,差异均有统计学意义(P<0.05),两组临床妊娠率比较无明显差异(P>0.05)。结论:对于年轻、卵巢储备正常的患者人群,长效长方案不失为控制性超排卵方案的一种好选择。 展开更多
关键词 促性腺激素释放激素激动剂 控制性超排卵 长方案 体外受精-胚胎移植
下载PDF
IVF促排卵过程中GnRH拮抗剂添加日LH水平对助孕结局的影响
15
作者 李桂桂 吴颖 张铭 《中国药师》 CAS 2024年第4期588-594,共7页
目的 探索体外受精-胚胎移植技术(IVF-ET)助孕过程中促性腺激素释放激素(GnRH)拮抗剂添加日血黄体生成素(LH)水平对妊娠结局和胚胎质量的影响。方法 回顾性分析2018年1月至2022年12月于武汉大学中南医院生殖医学中心接受拮抗剂方案常规I... 目的 探索体外受精-胚胎移植技术(IVF-ET)助孕过程中促性腺激素释放激素(GnRH)拮抗剂添加日血黄体生成素(LH)水平对妊娠结局和胚胎质量的影响。方法 回顾性分析2018年1月至2022年12月于武汉大学中南医院生殖医学中心接受拮抗剂方案常规IVF-ET治疗且预期卵巢正常反应的女性不孕症患者资料,根据其拮抗剂添加日LH水平进行分组,比较各组临床妊娠率、着床率、卵子成熟度、受精率、卵裂率、2原核胚胎比率、D3优质胚胎率、囊胚形成率,并绘制受试者工作特征(ROC)曲线评估LH水平对临床妊娠的预测价值。结果 研究共纳入188例患者,其拮抗剂添加日LH水平的中位值为3.79(2.48,6.14)mIU/mL。当LH <2.48 mIU/mL时鲜胚移植的临床妊娠率和着床率均最低(P <0.05),而LH> 6.14 mIU/mL时则具有最高的临床妊娠率和着床率(P <0.01),但各组之间的配子和胚胎发育参数差异无统计学意义(P>0.05)。ROC曲线下面积为0.678,LH水平对预测临床妊娠具有一定的准确性。结论 控制性超促排卵过程中LH水平高于6.14 mIU/mL时使用拮抗剂可获得最优的临床妊娠结局。 展开更多
关键词 控制性超促排卵 促性腺激素释放激素拮抗剂 临床妊娠率 黄体生成素水平
下载PDF
Effects of ovarian response prediction index and follicle-oocyte index on pregnancy outcomes:a retrospective cohort study of 12,218 fresh transfer cycles
16
作者 Mao Wang Li Tan +6 位作者 Yu-Bin Ding Xiao-Jun Tang Tian Li Xin-Yue Hu Hu-Cen Zhong Qi Wan Zhao-Hui Zhong 《Reproductive and Developmental Medicine》 CAS CSCD 2024年第3期151-161,共11页
Objective:To investigate the potential relationships among the ovarian response prediction index(ORPI),follicle-oocyte index(FOI),and clinical pregnancy rate(CPR)in women undergoing their first in vitro fertilization/... Objective:To investigate the potential relationships among the ovarian response prediction index(ORPI),follicle-oocyte index(FOI),and clinical pregnancy rate(CPR)in women undergoing their first in vitro fertilization/intracytoplasmic sperm injectionembryo transfer(IVF/ICSI-ET)fresh cycle transfer.Methods:In this retrospective cohort study,we included 12,218 women who underwent their first IVF/ICSI-ET cycle between December 2014 and January 2021.The primary and secondary outcomes of our study were CPR and cumulative live birth rate(CLBR),respectively.The data were divided into three groups according to the ORPI and FOI tertiles.Multivariate logistic regression analyses,stratification analyses,interaction,restricted cubic splines,and receiver operating characteristic(ROC)curves were constructed to identify the relationships among ORPI,FOI,and CPR.Results:A statistically significant increase in CPR was detected from the lowest to the highest tertile group(ORPI:48.12%,54.07%,and 53.47%,P<0.001;FOI:49.99%,52.95%,and 52.71%,P=0.012).A higher CLBR was observed in the high group(ORPI:38.63%,44.62%,and 44.19%,P<0.001;FOI:41.02%,43.78%,and 42.59%,P=0.039).Multivariate logistic regression analysis revealed no statistically significant differences between ORPI,FOI,and neither CPR(odds ratio[OR][95%confidence interval{CI}],0.99[0.97–1.00]vs.[1.02{0.84–1.24}])nor CLBR(OR[95%CI],0.99[0.97–1.01]vs.0.99[0.81–1.20]).No significant association was found among FOI,ORPI,and CPR,even in the subgroups.Restricted cubic spline analyses indicated the existence of a non-linear relationship across the entire range of FOI and ORPI.The ORPI and FOI variables had poor predictive ability(AUC<0.60)for CPR.Conclusions:Both ORPI and FOI are not reliable predictors of clinical pregnancy or live birth outcomes in fresh ETs.Clinicians and researchers should avoid using FOI and ORPI to assess pregnancy outcomes after fresh ET because of their limited relevance and predictive value. 展开更多
关键词 In vitro fertilization controlled ovarian hyperstimulation ovarian response indexes ovarian response prediction index Follicle-oocyte index Clinical pregnancy
原文传递
卵巢过度刺激综合征危险因素和预测模型的研究进展
17
作者 余良成 巨瑛 +2 位作者 王璐 陈书强 王晓红 《解放军医学院学报》 CAS 2024年第2期194-198,共5页
卵巢过度刺激综合征是控制性卵巢刺激过程中的常见并发症,不仅对胚胎移植策略产生影响,严重时甚至威胁患者的生命健康。目前已有越来越多的研究探讨卵巢过度刺激综合征的危险因素和生物标志物,并构建了一系列风险预测模型。本文对近年... 卵巢过度刺激综合征是控制性卵巢刺激过程中的常见并发症,不仅对胚胎移植策略产生影响,严重时甚至威胁患者的生命健康。目前已有越来越多的研究探讨卵巢过度刺激综合征的危险因素和生物标志物,并构建了一系列风险预测模型。本文对近年来卵巢过度刺激综合征的危险因素和风险预测模型的研究进展进行综述,以期为临床早期识别高危人群、及时制定有效预防措施提供依据,并为模型的选择和改良提供参考。 展开更多
关键词 控制性卵巢刺激 卵巢过度刺激综合征 危险因素 预测模型 研究进展
下载PDF
卵泡期与黄体期长方案鲜胚移植周期活产率和累积活产率比较
18
作者 郑娟 胡巨伟 周黎明 《生殖医学杂志》 CAS 2024年第5期599-604,共6页
目的比较卵泡期长方案与黄体期长效长方案促排卵后鲜胚移植周期的活产率和每取卵周期累积活产率,探讨两种垂体降调节方案的优劣势。方法回顾性分析2018年1月至2021年12月间于宁波大学附属妇女儿童医院生殖中心行体外受精-胚胎移植(IVF-... 目的比较卵泡期长方案与黄体期长效长方案促排卵后鲜胚移植周期的活产率和每取卵周期累积活产率,探讨两种垂体降调节方案的优劣势。方法回顾性分析2018年1月至2021年12月间于宁波大学附属妇女儿童医院生殖中心行体外受精-胚胎移植(IVF-ET)治疗、采用卵泡期长方案或黄体期长效长方案促排、卵巢储备功能正常患者的临床资料(共1969个周期),并根据促排卵方案不同分为卵泡期组(使用卵泡期长方案促排卵,461个周期)和黄体期组(使用黄体期长效长方案促排卵,1508个周期)。比较两组患者的一般情况及临床结局。结果两组患者的女性年龄、不孕年限、体质量指数(BMI)、抗苗勒管激素(AMH)水平、不孕原因等一般资料比较均无显著性差异(P>0.05)。卵泡期组的Gn天数显著高于黄体期组[(11.0±3.3)d vs.(10.6±3.1)d](P<0.01),Gn总剂量显著低于黄体期组[(2390.9±331.3)U vs.[(2645.5±308.1)U](P<0.01)。两组患者的优势卵泡数、获卵数及可利用胚胎数比较均无显著性差异(P>0.05)。卵泡期组HCG日E 2、LH及P水平均显著低于黄体期组(P<0.01)。两组患者的移植日内膜厚度、移植胚胎数比较均无显著性差异(P>0.05)。卵泡期组鲜胚移植周期活产率略低于黄体期组(44.81%vs.49.34%),差异尚无统计学意义(P=0.26)。卵泡期组的中重度卵巢过度刺激综合征(OHSS)发生率(0.87%vs.1.59%)及每取卵周期累计活产率(68.11%vs.70.76%)均略低于黄体期组,但差异尚无统计学意义(P>0.05)。结论对于卵巢储备功能正常的女性,使用卵泡期长方案促排卵可获得与黄体期长方案相似的临床结局。 展开更多
关键词 控制性促排卵 体外受精-胚胎移植 活产率 累积活产率
下载PDF
Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response 被引量:13
19
作者 Zhuo-ni XIAO Jia-li PENG +1 位作者 Jing YANG Wang-ming XU 《Current Medical Science》 SCIE CAS 2019年第3期431-436,共6页
Polycystic ovary syndrome (PCOS) is one of the most common causes of infertility in women. Progestin-primed ovarian stimulation (PPOS) protocol, which used oral progestin to prevent premature luteinizing hormone (LH) ... Polycystic ovary syndrome (PCOS) is one of the most common causes of infertility in women. Progestin-primed ovarian stimulation (PPOS) protocol, which used oral progestin to prevent premature luteinizing hormone (LH) surges in ovarian stimulation, has been proved to be effective and safe in patients with PCOS. The aim of the present study was to compare the efficacy of PPOS protocol with that of the traditional gonadotropin-releasing hormone (GnRH) antagonist protocol in patients with PCOS. A total of 157 patients undergoing in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) were recruited into this study. The patients were divided into two groups by the stimulation protocols: the GnRH antagonist protocol group and the PPOS protocol group. There was no significant difference in the clinical characteristics between the two groups. Dose and duration of gonadotropin were higher in the PPOS protocol group. Estradiol levels on the day of human chorionic gonadotropin (hCG) administration were significantly lower in the PPOS protocol group. Fertilization rates and the number of good quality embryos were similar between the two groups. Remarkably, we found 6 patients with moderate ovarian hyperstimulation syndrome (OHSS) in the GnRH antagonist protocol group but 0 in the PPOS protocol group. A total of 127 women completed their frozen embryo transfer (FET) cycles. There were no significant differences between the two groups in terms of clinical pregnancy rate per transfer, implantation rate, first-trimester miscarriage rate and on-going pregnancy rate per transfer. To conclude, PPOS protocol decreased the incidence of OHSS without adversely affecting clinical outcomes in patients with PCOS. 展开更多
关键词 polycystic ovary SYNDROME ovarian hyperstimulation SYNDROME progestin-primed ovarian stimulation GnRH antagonist PROTOCOL controlled ovarian hyperstimulation
下载PDF
反复控制性超促排卵对胚胎发育及妊娠结局的影响 被引量:2
20
作者 谢娟珂 张亚楠 +2 位作者 王倩 陈圆辉 张翠莲 《新乡医学院学报》 CAS 2023年第1期40-44,共5页
目的探讨反复控制性超促排卵(COH)对胚胎发育潜能及妊娠结局的影响。方法回顾性分析2014年1月至2020年7月于河南省人民医院生殖医学中心接受体外受精-胚胎移植(IVF-ET)助孕治疗的7086例患者的临床资料,根据COH次数将患者分为A组(首次行... 目的探讨反复控制性超促排卵(COH)对胚胎发育潜能及妊娠结局的影响。方法回顾性分析2014年1月至2020年7月于河南省人民医院生殖医学中心接受体外受精-胚胎移植(IVF-ET)助孕治疗的7086例患者的临床资料,根据COH次数将患者分为A组(首次行COH者)、B组(第2次行COH者)、C组(第3次或第4次行COH者),比较3组患者的胚胎发育指标(卵子成熟率、正常受精率、正常卵裂率、可利用胚胎率)和妊娠结局(胚胎种植率、生化妊娠率、临床妊娠率、异位妊娠率、流产率、早期流产率)。结果3组患者的卵子成熟率、正常受精率随COH次数的增加有下降趋势,但差异无统计学意义(P>0.05)。A组患者的正常卵裂率和可利用胚胎率均高于B组和C组(P<0.05);B组与C组患者的正常卵裂率、可利用胚胎率比较差异无统计学意义(P>0.05)。A组患者的胚胎种植率、生化妊娠率、临床妊娠率均显著高于B组和C组(P<0.05);B组与C组患者的胚胎种植率、生化妊娠率、临床妊娠率比较差异无统计学意义(P>0.05)。3组患者异位妊娠率比较差异无统计学意义(P>0.05)。B组患者的流产率和早期流产率高于A组(P<0.05);其余各组患者的流产率和早期流产率比较差异均无统计学意义(P>0.05)。结论反复COH可能会在一定程度上降低IVF-ET周期患者的正常卵裂率、可利用胚胎率、胚胎种植率、生化妊娠率、临床妊娠率及流产率。 展开更多
关键词 控制性超促排卵 胚胎发育 妊娠结局
下载PDF
上一页 1 2 23 下一页 到第
使用帮助 返回顶部